vs

Side-by-side financial comparison of Offerpad Solutions Inc. (OPAD) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $114.1M, roughly 2.0× Offerpad Solutions Inc.). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -34.5%). Offerpad Solutions Inc. produced more free cash flow last quarter ($65.7M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -36.8%).

Offerpad Solutions Inc is a prominent U.S. proptech firm focused on simplifying residential real estate transactions. Operating under the iBuyer model, it purchases homes directly from sellers, conducts required renovations, and resells properties to buyers. It also provides supporting services including mortgage assistance, title services, and flexible moving options for clients across dozens of U.S. states.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

OPAD vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
2.0× larger
ORGO
$225.6M
$114.1M
OPAD
Growing faster (revenue YoY)
ORGO
ORGO
+112.6% gap
ORGO
78.1%
-34.5%
OPAD
More free cash flow
OPAD
OPAD
$31.0M more FCF
OPAD
$65.7M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-36.8%
OPAD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPAD
OPAD
ORGO
ORGO
Revenue
$114.1M
$225.6M
Net Profit
$43.7M
Gross Margin
7.0%
Operating Margin
28.1%
Net Margin
19.4%
Revenue YoY
-34.5%
78.1%
Net Profit YoY
49.1%
469.5%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPAD
OPAD
ORGO
ORGO
Q4 25
$114.1M
$225.6M
Q3 25
$132.7M
$150.9M
Q2 25
$160.3M
$101.0M
Q1 25
$160.7M
$86.7M
Q4 24
$174.3M
$126.7M
Q3 24
$208.1M
$115.2M
Q2 24
$251.1M
$130.2M
Q1 24
$285.4M
$110.0M
Net Profit
OPAD
OPAD
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$-11.6M
$21.6M
Q2 25
$-10.9M
$-9.4M
Q1 25
$-15.1M
$-18.8M
Q4 24
$-17.3M
$7.7M
Q3 24
$-13.5M
$12.3M
Q2 24
$-13.8M
$-17.0M
Q1 24
$-17.5M
$-2.1M
Gross Margin
OPAD
OPAD
ORGO
ORGO
Q4 25
7.0%
Q3 25
7.0%
Q2 25
8.9%
Q1 25
6.5%
72.6%
Q4 24
6.1%
75.5%
Q3 24
8.2%
76.7%
Q2 24
8.7%
77.6%
Q1 24
7.9%
73.9%
Operating Margin
OPAD
OPAD
ORGO
ORGO
Q4 25
28.1%
Q3 25
-5.1%
13.7%
Q2 25
-4.9%
-12.5%
Q1 25
-7.2%
-30.9%
Q4 24
-7.8%
8.1%
Q3 24
-4.3%
5.4%
Q2 24
-3.9%
-10.7%
Q1 24
-4.8%
-3.5%
Net Margin
OPAD
OPAD
ORGO
ORGO
Q4 25
19.4%
Q3 25
-8.7%
14.3%
Q2 25
-6.8%
-9.3%
Q1 25
-9.4%
-21.7%
Q4 24
-9.9%
6.1%
Q3 24
-6.5%
10.7%
Q2 24
-5.5%
-13.1%
Q1 24
-6.1%
-1.9%
EPS (diluted)
OPAD
OPAD
ORGO
ORGO
Q4 25
$0.31
Q3 25
$-0.37
$0.11
Q2 25
$-0.39
$-0.10
Q1 25
$-0.55
$-0.17
Q4 24
$-0.64
$0.05
Q3 24
$-0.49
$0.09
Q2 24
$-0.50
$-0.13
Q1 24
$-0.64
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPAD
OPAD
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$26.5M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$38.2M
$300.1M
Total Assets
$154.8M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPAD
OPAD
ORGO
ORGO
Q4 25
$26.5M
$93.7M
Q3 25
$31.0M
$63.7M
Q2 25
$22.6M
$73.1M
Q1 25
$30.8M
$110.0M
Q4 24
$43.0M
$135.6M
Q3 24
$48.5M
$94.3M
Q2 24
$56.9M
$89.9M
Q1 24
$68.5M
$88.6M
Total Debt
OPAD
OPAD
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
OPAD
OPAD
ORGO
ORGO
Q4 25
$38.2M
$300.1M
Q3 25
$39.9M
$255.1M
Q2 25
$24.5M
$233.2M
Q1 25
$34.2M
$242.9M
Q4 24
$47.7M
$262.9M
Q3 24
$64.7M
$278.5M
Q2 24
$77.6M
$263.5M
Q1 24
$88.1M
$278.0M
Total Assets
OPAD
OPAD
ORGO
ORGO
Q4 25
$154.8M
$598.7M
Q3 25
$223.5M
$509.8M
Q2 25
$268.0M
$461.1M
Q1 25
$274.5M
$467.4M
Q4 24
$313.1M
$497.9M
Q3 24
$338.5M
$446.3M
Q2 24
$406.6M
$443.2M
Q1 24
$369.7M
$458.5M
Debt / Equity
OPAD
OPAD
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPAD
OPAD
ORGO
ORGO
Operating Cash FlowLast quarter
$66.8M
$39.4M
Free Cash FlowOCF − Capex
$65.7M
$34.8M
FCF MarginFCF / Revenue
57.6%
15.4%
Capex IntensityCapex / Revenue
0.9%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPAD
OPAD
ORGO
ORGO
Q4 25
$66.8M
$39.4M
Q3 25
$40.0M
$3.1M
Q2 25
$-13.5M
$-32.9M
Q1 25
$-10.2M
$-19.9M
Q4 24
$20.8M
$10.9M
Q3 24
$39.6M
$8.7M
Q2 24
$-54.4M
$4.7M
Q1 24
$2.4M
$-10.2M
Free Cash Flow
OPAD
OPAD
ORGO
ORGO
Q4 25
$65.7M
$34.8M
Q3 25
$844.0K
Q2 25
$-13.6M
$-36.5M
Q1 25
$-11.2M
$-23.6M
Q4 24
$15.4M
$7.6M
Q3 24
$38.7M
$6.1M
Q2 24
$-54.4M
$2.9M
Q1 24
$2.0M
$-12.4M
FCF Margin
OPAD
OPAD
ORGO
ORGO
Q4 25
57.6%
15.4%
Q3 25
0.6%
Q2 25
-8.5%
-36.1%
Q1 25
-7.0%
-27.2%
Q4 24
8.9%
6.0%
Q3 24
18.6%
5.3%
Q2 24
-21.7%
2.2%
Q1 24
0.7%
-11.3%
Capex Intensity
OPAD
OPAD
ORGO
ORGO
Q4 25
0.9%
2.1%
Q3 25
0.0%
1.5%
Q2 25
0.1%
3.6%
Q1 25
0.6%
4.2%
Q4 24
3.1%
2.7%
Q3 24
0.4%
2.2%
Q2 24
0.0%
1.4%
Q1 24
0.1%
2.0%
Cash Conversion
OPAD
OPAD
ORGO
ORGO
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons